New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Jarrow Introduces Ester Carnitine(TM)

Los Angeles, CA, May 10, 2005 — Los Angeles-based Jarrow Formulas’ has introduced Ester Carnitine™ (Glycine Propionyl-L-Carnitine HCI), a novel L-Carnitine molecule from Sigma-tau HealthScience and one of that company’s family of L-Carnitine products known as AminoCarnitines™. Jarrow Formulas enjoys a limited marketing exclusivity to the glycine propionyl-L-carnitine HCI form.

Ester Carnitine™ inaugurates the Next Generation of L-carnitine supplementation with the first muscle specific carnitine. Its components have been shown to increase muscle glycogen stores, reduce lactic acid build-up, maximize exercise endurance and reduce post-workout recovery time while improving the ability to oxidize fat for energy.

According to Sid Shastri, M.Sc., Vice President, Product Development for Jarrow Formulas, “Ester Carnitine™ is a propionyl ester of carnitine (PLC) that exhibits a special affinity for the carnitine acetyltransferase in muscle cells.”

It is a powerful scavenger against superoxide radicals and protects against lipid peroxidation. Ester Carnitine™ supports energy utilization by transport of fatty acids into myocellular mitochondria, as well as removal of waste substances from the mitochondria. Ester Carnitine™ supports muscular function by compensating for reduced oxygen availability during exercise.

“We are excited at the clinical collaboration between Jarrow Formulas, Sigma Tau and the University of Memphis – one that will elucidate the advantage of Ester Carnitine™,” says Shastri.

“Propionyl-L-Carnitine is one of the most thoroughly researched forms of L-carnitine and may influence oxygen utilization, enhance athletic performance and improve health,” says Dr. Richard Bloomer, Ph.D, who is currently an assistant professor within the Department of Health and Sport Sciences at The University of Memphis and spearheading the clinical work on the new AminoCarnitines™.

According to Jon David Szuch, National Sales Manager North America for Sigma-tau HealthScience, Inc, Jarrow Formulas has been a leading manufacturer and marketer for several decades in the nutritional supplement field. “They have been successful by using cutting edge technology and blazing many of the pathways forward for this industry only for others to follow,” he says. “Now, once again, Jarrow comes to the forefront of the US supplement industry by being one of the first to use new exclusive patented forms of Sigma-tau L-Carnitine molecules, such as Glycine Propionyl L-Carnitine Hydrochloride.”

Jarrow Formulas’ is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. The company markets its products throughout the United States and internationally in more than 20 countries in Europe, Asia, Israel and Latin America. The company offers a complete line of nutritional products that includes vitamins, minerals, specialty antioxidants, probiotics, amino acids, standardized herbal concentrates and enzymes. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain Americans’ rights to free access to dietary supplements. Its products are manufactured by Jarrow Industries Incorporated, a pharmaceutical quality facility located in Santa Fe Springs, CA.

For more information, contact Mark Becker, Director, Advertising/Communications toll free at (800) 726-0886 or access the Jarrow Formulas Web site at

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.